202 related articles for article (PubMed ID: 17881456)
1. Human immunodeficiency virus-specific CD8+ T-cell activity is detectable from birth in the majority of in utero-infected infants.
Thobakgale CF; Ramduth D; Reddy S; Mkhwanazi N; de Pierres C; Moodley E; Mphatswe W; Blanckenberg N; Cengimbo A; Prendergast A; Tudor-Williams G; Dong K; Jeena P; Kindra G; Bobat R; Coovadia H; Kiepiela P; Walker BD; Goulder PJ
J Virol; 2007 Dec; 81(23):12775-84. PubMed ID: 17881456
[TBL] [Abstract][Full Text] [Related]
2. Identification of human immunodeficiency virus-1 specific CD8+ and CD4+ T cell responses in perinatally-infected infants and their mothers.
Shalekoff S; Meddows-Taylor S; Gray GE; Sherman GG; Coovadia AH; Kuhn L; Tiemessen CT
AIDS; 2009 Apr; 23(7):789-98. PubMed ID: 19293686
[TBL] [Abstract][Full Text] [Related]
3. Combined Env- and Gag-specific T cell responses in relation to programmed death-1 receptor and CD4 T cell loss rates in human immunodeficiency virus-1 infection.
Pettersen FO; Taskén K; Kvale D
Clin Exp Immunol; 2010 Aug; 161(2):315-23. PubMed ID: 20491784
[TBL] [Abstract][Full Text] [Related]
4. Role of human immunodeficiency virus (HIV)-specific T-cell immunity in control of dual HIV-1 and HIV-2 infection.
Zheng NN; McElrath MJ; Sow PS; Hawes SE; Diallo-Agne H; Stern JE; Li F; Mesher AL; Robinson AD; Gottlieb GS; Huang Y; Kiviat NB
J Virol; 2007 Sep; 81(17):9061-71. PubMed ID: 17582003
[TBL] [Abstract][Full Text] [Related]
5. Strong HIV-1-specific T cell responses in HIV-1-exposed uninfected infants and neonates revealed after regulatory T cell removal.
Legrand FA; Nixon DF; Loo CP; Ono E; Chapman JM; Miyamoto M; Diaz RS; Santos AM; Succi RC; Abadi J; Rosenberg MG; de Moraes-Pinto MI; Kallas EG
PLoS One; 2006 Dec; 1(1):e102. PubMed ID: 17183635
[TBL] [Abstract][Full Text] [Related]
6. Virological and immunological characterization of novel NYVAC-based HIV/AIDS vaccine candidates expressing clade C trimeric soluble gp140(ZM96) and Gag(ZM96)-Pol-Nef(CN54) as virus-like particles.
Perdiguero B; Gómez CE; Cepeda V; Sánchez-Sampedro L; García-Arriaza J; Mejías-Pérez E; Jiménez V; Sánchez C; Sorzano CÓ; Oliveros JC; Delaloye J; Roger T; Calandra T; Asbach B; Wagner R; Kibler KV; Jacobs BL; Pantaleo G; Esteban M
J Virol; 2015 Jan; 89(2):970-88. PubMed ID: 25355891
[TBL] [Abstract][Full Text] [Related]
7. Early Gag immunodominance of the HIV-specific T-cell response during acute/early infection is associated with higher CD8+ T-cell antiviral activity and correlates with preservation of the CD4+ T-cell compartment.
Turk G; Ghiglione Y; Falivene J; Socias ME; Laufer N; Coloccini RS; Rodriguez AM; Ruiz MJ; Pando MÁ; Giavedoni LD; Cahn P; Sued O; Salomon H; Gherardi MM
J Virol; 2013 Jul; 87(13):7445-62. PubMed ID: 23616666
[TBL] [Abstract][Full Text] [Related]
8. mRNA-based dendritic cell vaccination induces potent antiviral T-cell responses in HIV-1-infected patients.
Van Gulck E; Vlieghe E; Vekemans M; Van Tendeloo VF; Van De Velde A; Smits E; Anguille S; Cools N; Goossens H; Mertens L; De Haes W; Wong J; Florence E; Vanham G; Berneman ZN
AIDS; 2012 Feb; 26(4):F1-12. PubMed ID: 22156965
[TBL] [Abstract][Full Text] [Related]
9. Terminally differentiated CD8 cells in HIV-infected children: HIV-GAG/POL specificity and IFN-γ production.
Delbeck D; Siepermann M; Feyen O; Wirth S; Baumann U; Wintergerst U; Oette M; Adam R; Jetzek-Zader M; Niehues T
Klin Padiatr; 2011 Jul; 223(4):214-20. PubMed ID: 21472637
[TBL] [Abstract][Full Text] [Related]
10. New CD4+ and CD8+ T cell responses induced in chronically HIV type-1-infected patients after immunizations with an HIV type 1 lipopeptide vaccine.
Gahery H; Daniel N; Charmeteau B; Ourth L; Jackson A; Andrieu M; Choppin J; Salmon D; Pialoux G; Guillet JG
AIDS Res Hum Retroviruses; 2006 Jul; 22(7):684-94. PubMed ID: 16831093
[TBL] [Abstract][Full Text] [Related]
11. Immune-correlates analysis of an HIV-1 vaccine efficacy trial reveals an association of nonspecific interferon-γ secretion with increased HIV-1 infection risk: a cohort-based modeling study.
Huang Y; Duerr A; Frahm N; Zhang L; Moodie Z; De Rosa S; McElrath MJ; Gilbert PB
PLoS One; 2014; 9(11):e108631. PubMed ID: 25369172
[TBL] [Abstract][Full Text] [Related]
12. Suppression of viral replication with highly active antiretroviral therapy has no impact on the functional profile of HIV-specific CD8(+) T cells.
López M; Soriano V; Rallón N; Cascajero A; González-Lahoz J; Benito JM
Eur J Immunol; 2008 Jun; 38(6):1548-58. PubMed ID: 18421792
[TBL] [Abstract][Full Text] [Related]
13. Deficiency of HIV-Gag-specific T cells in early childhood correlates with poor viral containment.
Huang S; Dunkley-Thompson J; Tang Y; Macklin EA; Steel-Duncan J; Singh-Minott I; Ryland EG; Smikle M; Walker BD; Christie CD; Feeney ME
J Immunol; 2008 Dec; 181(11):8103-11. PubMed ID: 19018003
[TBL] [Abstract][Full Text] [Related]
14. T-cell responses targeting HIV Nef uniquely correlate with infected cell frequencies after long-term antiretroviral therapy.
Thomas AS; Jones KL; Gandhi RT; McMahon DK; Cyktor JC; Chan D; Huang SH; Truong R; Bosque A; Macedo AB; Kovacs C; Benko E; Eron JJ; Bosch RJ; Lalama CM; Simmens S; Walker BD; Mellors JW; Jones RB
PLoS Pathog; 2017 Sep; 13(9):e1006629. PubMed ID: 28931091
[TBL] [Abstract][Full Text] [Related]
15. Reduced markers of HIV persistence and restricted HIV-specific immune responses after early antiretroviral therapy in children.
Ananworanich J; Puthanakit T; Suntarattiwong P; Chokephaibulkit K; Kerr SJ; Fromentin R; Bakeman W; Intasan J; Mahanontharit A; Sirivichayakul S; Chomont N;
AIDS; 2014 Apr; 28(7):1015-20. PubMed ID: 24384692
[TBL] [Abstract][Full Text] [Related]
16. HIV-1-specific CD8+ T cell responses and viral evolution in women and infants.
Sanchez-Merino V; Nie S; Luzuriaga K
J Immunol; 2005 Nov; 175(10):6976-86. PubMed ID: 16272358
[TBL] [Abstract][Full Text] [Related]
17. Multiple T-cell responses to human immunodeficiency virus type 1 are enhanced by dendritic cells.
Huang XL; Fan Z; Borowski L; Rinaldo CR
Clin Vaccine Immunol; 2009 Oct; 16(10):1504-16. PubMed ID: 19692626
[TBL] [Abstract][Full Text] [Related]
18. HIV-specific gag responses in early infancy correlate with clinical outcome and inversely with viral load.
Nqoko B; Day CL; Mansoor N; De Kock M; Hughes EJ; Hawkridge T; Kaplan G; Boom WH; Hussey GD; Hanekom WA
AIDS Res Hum Retroviruses; 2011 Dec; 27(12):1311-6. PubMed ID: 21476948
[TBL] [Abstract][Full Text] [Related]
19. Multi-layered Gag-specific immunodominant responses contribute to improved viral control in the CRF01_AE subtype of HIV-1-infected MSM subjects.
Jiang F; Han X; Zhang H; Zhao B; An M; Xu J; Chu Z; Dong T; Shang H
BMC Immunol; 2016 Aug; 17(1):28. PubMed ID: 27577610
[TBL] [Abstract][Full Text] [Related]
20. Enhanced anti-HIV functional activity associated with Gag-specific CD8 T-cell responses.
Julg B; Williams KL; Reddy S; Bishop K; Qi Y; Carrington M; Goulder PJ; Ndung'u T; Walker BD
J Virol; 2010 Jun; 84(11):5540-9. PubMed ID: 20335261
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
